FDA Creates Position To Respond To Congress’s Request For Information
This article was originally published in The Tan Sheet
Executive Summary
FDA has created the position of senior legislative analyst for oversight in response to a rising tide of congressional requests for information on topics including food safety as well as OTC and Rx drug issues
You may also be interested in...
House Members Question FDA Lab Closures As Food Safety Problems Mount
House Energy and Commerce Committee members say FDA's plans to close more than half its field labs heighten their concerns about its ability to secure the U.S. food supply
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers